PHIBRO ANIMAL HEALTH CORP (PAHC)

38.23 -0.34 (-0.88%)

As of 2025-10-16 17:55:06 EST

Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated in Delaware.

Traded asNasdaq: PAHC
ISINUS71742Q1067
CIK0001069899
LEI549300U24SP4AF2JUX52
EIN131840497
Sector—
IndustryPharmaceutical Preparations
CEO—
Employees1,400
Fiscal Year End0630
AddressGLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666
Phone201-329-7300
Websitehttps://pahc.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
PAHCPHIBRO ANIMAL HEALTH CORP2025-10-16 17:55:0638.23-0.34-0.88
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
PAHC0001069899PHIBRO ANIMAL HEALTH CORPUS71742Q1067549300U24SP4AF2JUX52131840497Nasdaq2834Pharmaceutical Preparations0630DEGLENPOINTE CENTRE EAST, 3RD FLOORTEANECKNJ07666UNITED STATESUS201-329-7300GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666PHILIPP BROTHERS CHEMICALS INC———1,400https://pahc.com/422,641,76568,910,000—Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated in Delaware.2025-10-10 20:55:04
This is a preview of the latest data. Subscribe to access the full data.
PAHC Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
PAHC Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025422,641,765187,821,43679.9852———
2024234,820,329-37,108,912-13.6465———
2023271,929,241-142,149,438-34.3291———
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Larry L. MillerChief Operating Officer2022634,9950—320,00043,826998,821
Rob AukermanPresident2022463,950105,000—194,95043,540807,440
Jack C. BendheimChief Executive Officer, President, Chairman Of The Board20222,185,0000—1,055,000324,8293,609,499
Damian FinioChief Financial Officer2022462,3750—227,00030,006719,381
Daniel M. BendheimDirector, Executive Vice President2022441,8250—217,00030,916689,741
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20252,475
20241,940
20231,920
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue1,296,215,0001,017,679,000977,889,000
Cost Of Revenue896,273,000704,587,000679,652,000
Gross Profit399,942,000313,092,000298,237,000
Research And Development Expenses23,726,00029,194,00024,395,000
General And Administrative Expenses289,477,000259,777,000226,390,000
Operating Expenses———
Operating Income110,465,00053,315,00071,847,000
Net Income48,264,0002,416,00032,606,000
Earnings Per Share Basic1.190.060.81
Earnings Per Share Diluted1.190.060.81
Weighted Average Shares Outstanding Basic40,515,00040,504,00040,504,000
Weighted Average Shares Outstanding Diluted40,678,00040,523,00040,504,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents68,039,00070,613,00041,281,000
Marketable Securities Current9,000,00044,000,00040,000,000
Accounts Receivable227,983,000169,452,000163,479,000
Inventories444,425,000265,911,000277,570,000
Non Trade Receivables———
Other Assets Current61,159,00051,021,00063,393,000
Total Assets Current810,606,000600,997,000585,723,000
Marketable Securities Non Current———
Property Plant And Equipment354,690,000203,300,000195,568,000
Other Assets Non Current99,490,00078,297,00081,845,000
Total Assets Non Current550,294,000381,187,000385,674,000
Total Assets1,360,900,000982,184,000971,397,000
Accounts Payable138,201,00085,567,00073,853,000
Deferred Revenue——370,000
Short Term Debt16,250,00029,795,00022,295,000
Other Liabilities Current31,237,00017,540,00018,859,000
Total Liabilities Current293,473,000204,148,000176,000,000
Long Term Debt631,685,000312,084,000333,836,000
Other Liabilities Non Current79,310,00063,106,00060,347,000
Total Liabilities Non Current781,745,000521,395,000512,888,000
Total Liabilities1,075,218,000725,543,000688,888,000
Common Stock4,0004,0004,000
Retained Earnings272,701,000243,886,000260,912,000
Accumulated Other Comprehensive Income-124,018,000-123,527,000-114,210,000
Total Shareholders Equity285,682,000256,641,000282,509,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization45,605,00036,178,00034,012,000
Share Based Compensation Expense717,000475,000—
Other Non Cash Income Expense1,643,0002,098,000-334,000
Change In Accounts Receivable55,208,0008,678,000-5,335,000
Change In Inventories44,294,000-2,641,00011,222,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable45,555,00012,000,000-22,830,000
Change In Other Liabilities———
Cash From Operating Activities80,124,00087,594,00013,310,000
Purchases Of Marketable Securities14,000,00065,523,00040,000,000
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment38,293,00041,238,00051,794,000
Acquisition Of Business286,529,0003,282,000—
Other Investing Activities-1,134,000-326,000-776,000
Cash From Investing Activities-288,688,000-48,194,000-74,018,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends19,449,00019,442,00019,442,000
Issuance Of Common Stock———
Repurchase Of Common Stock———
Issuance Of Long Term Debt532,000,000276,000,000264,000,000
Repayment Of Long Term Debt—35,00035,000
Other Financing Activities———
Cash From Financing Activities207,134,000-6,768,00026,987,000
Change In Cash-2,574,00029,332,000-32,967,000
Cash At End Of Period68,039,00070,613,00041,281,000
Income Taxes Paid13,400,00015,430,00020,410,000
Interest Paid32,073,00017,253,00014,575,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share1.190.060.81
Price To Earnings Ratio21.462228416.9136
Earnings Growth Rate1,883.3333-92.5926-33.0579
Price Earnings To Growth Ratio0.0114-3.0672-0.5116
Book Value Per Share7.05136.33626.9748
Price To Book Ratio3.6222.68931.9642
Ebitda144,493,00077,034,000105,704,000
Enterprise Value1,614,649,100961,454,160869,754,800
Dividend Yield0.01880.02820.035
Dividend Payout Ratio0.4038.04720.5963
Debt To Equity Ratio2.2681.33211.2606
Capital Expenditures196,995,00043,910,00064,090,000
Free Cash Flow-116,871,00043,684,000-50,780,000
Return On Equity0.16890.00940.1154
One Year Beta1.16190.83950.7624
Three Year Beta0.95170.74380.7473
Five Year Beta0.86610.8930.8814
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
BENDHEIM JACKDirector, President and CEO, 10% owner2025-09-3020,664D40,674
BENDHEIM JACKDirector, President and CEO, 10% owner2025-09-1930,000A61,338
BENDHEIM JACKDirector, President and CEO, 10% owner2025-09-1930,000D20,136,034
BENDHEIM JACKDirector, President and CEO, 10% owner2025-09-187,022D31,338
BENDHEIM JACKDirector, President and CEO, 10% owner2025-09-113,520D38,360
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Capital Advisors, Ltd. LLC2025-09-301,0002245.4545
CWM, LLC2025-09-30130,0003,21740.4103
Inspire Investing, LLC2025-09-301,063,97726,29740.46
HARBOR CAPITAL ADVISORS, INC.2025-09-30428,00010,58940.4193
YOUSIF CAPITAL MANAGEMENT, LLC2025-09-30260,6846,44340.46
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
ETF Series Solutions2025-07-31AAM SAWGRASS U.S. SMALL CAP QUALITY GROWTH ETFSAWS82521,862.51.3973
Advisors' Inner Circle Fund III2025-07-31I SharesKCXIX912,411.50.001
INVESCO EXCHANGE-TRADED FUND TRUST2025-07-31Invesco RAFI US 1500 Small-Mid ETFPRFZ46,1101,221,9150.0516
INVESCO EXCHANGE-TRADED FUND TRUST2025-07-31Invesco S&P SmallCap 600 Pure Growth ETFRZG26,846711,4190.7207
Global X Funds2025-07-31Global X Russell 2000 ETFRSSL10,392275,3880.0209
This is a preview of the latest data. Subscribe to access the full data.